Edesa Biotech Inc (EDSA)
4.420
-0.05
(-1.09%)
USD |
NASDAQ |
Apr 26, 16:00
Edesa Biotech Total Return Level: 4.420 for April 26, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 26, 2024 | 4.420 |
April 25, 2024 | 4.468 |
April 24, 2024 | 4.31 |
April 23, 2024 | 4.465 |
April 22, 2024 | 4.38 |
April 19, 2024 | 4.45 |
April 18, 2024 | 4.36 |
April 17, 2024 | 4.40 |
April 16, 2024 | 4.346 |
April 15, 2024 | 4.16 |
April 12, 2024 | 4.480 |
April 11, 2024 | 4.48 |
April 10, 2024 | 4.685 |
April 09, 2024 | 4.540 |
April 08, 2024 | 4.65 |
April 05, 2024 | 4.675 |
April 04, 2024 | 4.800 |
April 03, 2024 | 4.36 |
April 02, 2024 | 4.40 |
April 01, 2024 | 4.24 |
March 28, 2024 | 4.192 |
March 27, 2024 | 4.45 |
March 26, 2024 | 4.12 |
March 25, 2024 | 4.178 |
March 22, 2024 | 4.28 |
Date | Value |
---|---|
March 21, 2024 | 4.09 |
March 20, 2024 | 4.32 |
March 19, 2024 | 4.11 |
March 18, 2024 | 4.30 |
March 15, 2024 | 4.39 |
March 14, 2024 | 4.36 |
March 13, 2024 | 4.33 |
March 12, 2024 | 4.55 |
March 11, 2024 | 4.56 |
March 08, 2024 | 4.528 |
March 07, 2024 | 4.35 |
March 06, 2024 | 4.315 |
March 05, 2024 | 4.41 |
March 04, 2024 | 4.55 |
March 01, 2024 | 4.81 |
February 29, 2024 | 4.618 |
February 28, 2024 | 4.96 |
February 27, 2024 | 5.00 |
February 26, 2024 | 5.011 |
February 23, 2024 | 4.99 |
February 22, 2024 | 4.70 |
February 21, 2024 | 5.16 |
February 20, 2024 | 5.440 |
February 16, 2024 | 5.37 |
February 15, 2024 | 5.65 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
2.55
Minimum
Nov 13 2023
83.44
Maximum
Sep 20 2021
24.90
Average
23.38
Median
Jan 23 2020
Total Return Level Benchmarks
Acasti Pharma Inc | 2.90 |
Aurinia Pharmaceuticals Inc | 4.91 |
Lexaria Bioscience Corp | 2.35 |
Xenon Pharmaceuticals Inc | 40.50 |
ESSA Pharma Inc | 6.08 |